@callfly3
-
Battle Vestergaard posted an update 6 months, 1 week ago
Protein tyrosine kinase 6 (PTK6) is the most well studied member of the PTK6 family of intracellular tyrosine kinases. While it is expressed at highest levels in differentiated cells in the regenerating epithelial linings of the gastrointestinal tract and skin, induction and activation of PTK6 is detected in several cancers, including breast and…[Read more]
-
Battle Vestergaard posted an update 6 months, 2 weeks ago
Antibodies that develop in patients with immune thrombotic thrombocytopenic purpura (iTTP) commonly target the spacer epitope R568/F592/R660/Y661/Y665 (RFRYY). In this study we present a detailed contribution of each residue in this epitope for autoantibody binding. Different panels of mutations were introduced here to create a large collection of…[Read more]
-
Battle Vestergaard posted an update 6 months, 2 weeks ago
Current guidelines strongly recommend high-intensity statin therapy after acute myocardial infarction.
To analyse the relationship between prescription of high-intensity statin therapy at discharge and long-term clinical outcomes according to risk level defined by the Thrombolysis In Myocardial Infarction Risk Score for Secondary…[Read more]
-
Battle Vestergaard posted an update 6 months, 2 weeks ago
To the best of the authors’ knowledge, no previous studies have described the effect of branched-chain amino acids (BCAA) on vertical performance during a week in professional volleyball players. This study assessed BCAA supplementation for a week, aiming to improve vertical jump performance in male professional volleyball players. Twelve male…[Read more]
-
Battle Vestergaard became a registered member 6 months, 2 weeks ago